Interventions for preventing the progression of autosomal dominant polycystic kidney disease-Reference-Cited by-同舟云学术

Interventions for preventing the progression of autosomal dominant polycystic kidney disease

Published:2015-07-14 Issue:9 Volume:2015 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Bolignano Davide¹,Palmer Suetonia C²,Ruospo Marinella³⁴,Zoccali Carmine¹,Craig Jonathan C⁵⁶,Strippoli Giovanni FM³⁶⁷⁸

Affiliation:

1. CNR - Italian National Council of Research; Institute of Clinical Physiology; CNR-IFC Via Vallone Petrara c/o Ospedali Riuniti Reggio Calabria Italy 89100

2. University of Otago Christchurch; Department of Medicine; 2 Riccarton Ave PO Box 4345 Christchurch New Zealand 8140

3. Diaverum; Medical Scientific Office; Lund Sweden

4. Amedeo Avogadro University of Eastern Piedmont; Division of Nephrology and Transplantation, Department of Translational Medicine; Via Solaroli 17 Novara Italy 28100

5. The University of Sydney; Sydney School of Public Health; Edward Ford Building A27 Sydney NSW Australia 2006

6. The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145

7. University of Bari; Department of Emergency and Organ Transplantation; Bari Italy

8. Diaverum Academy; Bari Italy

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD010294.pub2/fullpdf

Reference132 articles.

1. Effect of benazepril in chronic renal insufficiency;Apperloo;New England Journal of Medicine,1996

2. Effect of benazepril in chronic renal insufficiency;Curren;New England Journal of Medicine,1996

3. Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluation;Hogan;Pharmacoeconomics,2002

4. Long-term progression of chronic renal insufficiency in the AIPRI Extension Study. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group;Locatelli;Kidney International - Supplement,1997

5. The role of underlying nephropathy in the progression of renal disease;Locatelli;Kidney International - Supplement,2000

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transplantation versus other therapies for patients with polycystic liver disease;Cochrane Database of Systematic Reviews;2022-06-22

2. Research priorities for autosomal dominant polycystic kidney disease: a UK priority setting partnership;BMJ Open;2022-06

3. Somatostatin analog therapy effectiveness on the progression of polycystic kidney and liver disease: A systematic review and meta-analysis of randomized clinical trials;PLOS ONE;2021-09-24

4. Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease;BMC Nephrology;2021-03-25

5. The wind of change in the management of autosomal dominant polycystic kidney disease in childhood;Pediatric Nephrology;2021-03-07